The Relevance of Research Study Phase to Disclosure of Off-Label Drug Availability

&
American Journal of Bioethics 14 (4):53-54 (2014)
  Copy   BIBTEX

Abstract

No abstract

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2014.889950

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics.Claudia Wiesemann - 2009 - European Journal of Pediatrics 168:1473-1478.
Rooting Out Institutional Corruption to Manage Inappropriate Off‐Label Drug Use.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):654-664.
Off-Label Drug Use as a Consent and Health Regulation Issue in New Zealand.Rebecca Julia Cook - 2015 - Journal of Bioethical Inquiry 12 (2):251-258.
When research seems like clinical care: a qualitative study of the communication of individual cancer genetic research results.Fiona A. Miller, Mita Giacomini, Catherine Ahern, Jason S. Robert & Sonya de Laat - 2008 - BMC Medical Ethics 9 (1):4.
Speaking Off Label.Stephen R. Latham - 2010 - Hastings Center Report 40 (6):9-10.
A call to restructure the drug development process: Government over-regulation and non-innovative late stage (phase III) clinical trials are major obstacles to advances in health care.Thomas C. Jones - 2005 - Science and Engineering Ethics 11 (4):575-587.
Risk of disclosure of participating in an internet-based HIV behavioural risk study of men who have sex with men.C. M. Khosropour & P. S. Sullivan - 2011 - Journal of Medical Ethics 37 (12):768-769.
Reporting of ethical requirements in phase III surgical trials.Valérie Bridoux, Lilian Schwarz, Grégoire Moutel, Francis Michot, Christian Herve & Jean-Jacques Tuech - 2014 - Journal of Medical Ethics 40 (10):687-690.
Acceptable risks and burdens for children in research without direct benefit: a systematic analysis of the decisions made by the Dutch Central Committee.A. E. Westra, R. N. Sukhai, J. M. Wit, I. D. de Beaufort & A. F. Cohen - 2010 - Journal of Medical Ethics 36 (7):420-424.
The Ethics of Disclosing to Research Subjects the Availability of Off-Label Marketed Drugs.Holly A. Taylor, Ellen Kuwana & Benjamin S. Wilfond - 2014 - American Journal of Bioethics 14 (4):51-51.
Ethics of research involving mandatory drug testing of high school athletes in oregon.Adil E. Shamoo & Jonathan D. Moreno - 2004 - American Journal of Bioethics 4 (1):25 – 31.
'Normalising' drug use?: What does the 'pro-drug' lobby's law reform agenda affirm and reinforce in their current endeavours to 'normalise' drug use? [REVIEW]Shane Varcoe - 2011 - Bioethics Research Notes 23 (4):56.
Good intentions and dangerous assumptions: Research ethics committees and illicit drug use research.Kirsten Bell & Amy Salmon - 2012 - Research Ethics 8 (4):191-199.
Drug use as consumer behavior.Gordon Robert Foxall & Valdimar Sigurdsson - 2011 - Behavioral and Brain Sciences 34 (6):313-314.
Drug regulation in the philippines.Allan Grand A. Sobrepena - unknown

Analytics

Added to PP
2014-04-15

Downloads
17 (#819,600)

6 months
4 (#698,851)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references